[Significance of molecular classification in fertility-sparing treatment of endometrial carcinoma and atypical endometrial hyperplasia].

Wang, Y Q; Kang, N; Li, L W; Wang, Z Q; Zhou, R; Shen, D H; Wang, J L

Wang, Y Q; Kang, N; Li, L W; Wang, Z Q; Zhou, R; Shen, D H; Wang, J L.

Afiliación

Wang YQ; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Kang N; Department of Pathology, Peking University People's Hospital, Beijing 100044, China.
Li LW; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Wang ZQ; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Zhou R; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Shen DH; Department of Pathology, Peking University People's Hospital, Beijing 100044, China.
Wang JL; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.

Zhonghua Fu Chan Ke Za Zhi ; 57(9): 692-700, 2022 Sep 25.

Article en Zh | MEDLINE | ID: mdl-36177581

Asunto(s)

Hiperplasia Endometrial; Neoplasias Endometriales; Preservación de la Fertilidad; Adulto; Antígeno Ca-125; Hiperplasia Endometrial/tratamiento farmacológico; Hiperplasia Endometrial/genética; Neoplasias Endometriales/tratamiento farmacológico; Neoplasias Endometriales/terapia; Femenino; Humanos; Antígeno Ki-67; Estudios Retrospectivos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Hiperplasia Endometrial / Preservación de la Fertilidad Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Female / Humans Idioma: Zh Revista: Zhonghua Fu Chan Ke Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google